Entrada Therapeutics Inc
Biotechnology
Healthcare
TRDA
41.00 M shares
NASDAQ US
traded
25 Jun 2025
listed
no
open
7.07
52 week high
21.59
high
7.19
52 week low
7.03
previous Close
7.08
P/E ratio
market cap
651 M
div yield
0
net incoming
-14.03 M
-125.50 %
net profit margin
-71.70 %
-129.00 %
operating incoming
-21.66 M
-140.54 %
net change in cash
-107.20 M
-191.77 %
cash on hand
78.05 M
-57.87 %
cost of revenue
900 K
0.00 %
top